FN2 Earnings Intelligence
CME Group Inc. income statement
CME Group Inc. (CME) Income Statement (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $2,834.9 | $2,720.1 | $2,912 | $2,892.4 | $4,416.9 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $4,689.7 | $5,019.4 | $5,578.9 | $6,130.1 | $6,520.6 | $7,028.9 | $7,383.1 |
| % Growth | -4.0% | 7.0% | 11.1% | 9.9% | 6.4% | 7.8% | 5.0% |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | $2,793 | $3,150.8 | $3,561.7 | $4,046.6 | $4,337 | - | - |
| % Margin | 59.6% | 62.8% | 63.8% | 66.0% | 66.5% | - | - |
| Net Income | $2,636.4 | $2,691 | $3,226.2 | $3,525.8 | $4,072.2 | - | - |
| % Margin | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% | - | - |
| Diluted EPS | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 | $12.25 | $12.92 |
| % Growth | 24.2% | 1.5% | 19.7% | 9.1% | 15.4% | 9.8% | 5.5% |
| Operating Cash Flow | $2,402.4 | $3,056 | $3,453.8 | $3,690.5 | $4,277.1 | - | - |
| CapEx | $127.2 | $89.7 | $76.4 | $94 | $83.5 | - | - |
| Free Cash Flow | $2,275.2 | $2,966.3 | $3,377.4 | $3,596.5 | $4,193.6 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $4,689.7 | $5,019.4 | $5,578.9 | $6,130.1 | $6,520.6 | $7,028.9 | $7,383.1 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | $2,793 | $3,150.8 | $3,561.7 | $4,046.6 | $4,337 | - | - |
| Net Income | $2,636.4 | $2,691 | $3,226.2 | $3,525.8 | $4,072.2 | - | - |
| Diluted EPS | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 | $12.25 | $12.92 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,834.9 | $2,720.1 | $2,912 | $2,892.4 | $4,416.9 |
| Short-term Debt | $749.4 | $16 | $0 | $749.8 | $0 |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,402.4 | $3,056 | $3,453.8 | $3,690.5 | $4,277.1 |
| Capital Expenditure | $127.2 | $89.7 | $76.4 | $94 | $83.5 |
| Free Cash Flow | $2,275.2 | $2,966.3 | $3,377.4 | $3,596.5 | $4,193.6 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | -4.0% | 7.0% | 11.1% | 9.9% | 6.4% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 59.6% | 62.8% | 63.8% | 66.0% | 66.5% |
| Net Margin | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% |
| FCF Margin | 48.5% | 59.1% | 60.5% | 58.7% | 64.3% |
| Diluted EPS Growth | 24.2% | 1.5% | 19.7% | 9.1% | 15.4% |